• 11/11/2024

Biotech Startup Maze Therapeutics Strikes $750 Million Deal With Sanofi

Wall Street Journal

Maze Therapeutics has raised about $400 million in venture capital since its 2019 launch on the promise of a platform for using genetic insights to develop new drugs. Now, the biotechnology startup is making good on that potential.

https://www.wsj.com/articles/biotech-startup-maze-therapeutics-strikes-750-million-deal-with-sanofi-874d3f99